Phytosterols reduce in vitro metastatic ability of MDA-MB-231 human breast cancer cells.
Metastasis plays a major role in morbidity and mortality from breast cancer. Differences in the incidence and mortality of breast cancer between societies suggest that environmental factors such as diet may play a role in the disease. Previous work from this laboratory suggests that dietary phytosterols (PS) may offer protection from breast cancer by inhibiting growth of the tumor and its metastasis in severe combined immunodeficient mice. Because metastasis is a multistep process, the aim of the present study was to investigate the effect of PS on some steps of the metastatic process: tumor cell invasion, adhesion, and migration. In addition, cell growth and cell cycle progression were evaluated. MDA-MB-231 cells were supplemented with cholesterol, beta-sitosterol, and campesterol. Cells were treated for 3 days with 16 microM sterol that was loaded on 5 mM cyclodextrin. beta-Sitosterol inhibited tumor cell invasion through Matrigel and adhesion of cells to plates coated with collagen I, collagen IV, fibronectin, and laminin compared with cholesterol treatments and controls. Cholesterol treatment resulted in increased adhesion to laminin and collagen IV, two basement membrane (BM) components that are implicated in signaling tumor cell invasion in this cell line. Only cholesterol treatment increased cellular migration. beta-Sitosterol inhibited cell growth by 70% compared with controls and induced cell cycle arrest at the G2/M phase. It is concluded that, among PS, beta-sitosterol may offer protection from breast cancer metastasis by inhibiting cell invasion of the BM, which may be mediated by its ability to limit the adhesive interaction of the tumor cell and the BM.
Awad
A B
AB
Department of Physical Therapy, Exercise and Nutrition Sciences, State University of New York at Buffalo, Buffalo, NY 14214, USA. awad@acsu.buffalo.edu
Williams
H
H
Fink
C S
CS
D001943:Breast Neoplasms / Q000473:pathology*; D002448:Cell Adhesion; D002455:Cell Division / Q000187:drug effects; D002465:Cell Movement / Q000187:drug effects; D003094:Collagen; D024042:Collagen Type I; D024141:Collagen Type IV; D004338:Drug Combinations; D005353:Fibronectins; D016195:G2 Phase; D006801:Humans; D007797:Laminin; D008938:Mitosis; D009361:Neoplasm Invasiveness / Q000473:pathology; D009362:Neoplasm Metastasis / Q000517:prevention & control*; D010840:Phytosterols / Q000494:pharmacology*; D011509:Proteoglycans; D012855:Sitosterols / Q000494:pharmacology; D013261:Sterols / Q000378:metabolism; D014407:Tumor Cells, Cultured
D024042:Collagen Type I; D024141:Collagen Type IV; D004338:Drug Combinations; D005353:Fibronectins; D007797:Laminin; D010840:Phytosterols; D011509:Proteoglycans; D012855:Sitosterols; D013261:Sterols; C059485:matrigel; C025473:gamma-sitosterol; D003094:Collagen